Gian Domenico Iannetti

Gian Domenico Iannetti

Auto-generated profile, based on publicly available information

Gian Domenico Iannetti

Italian Institute of Technology

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Pain
Verified
Journal Article
Closed access
MHMaija Haanpää
Maija Haanpää
NANadine Attal
Nadine Attal
MBMiroslav Backonja
Miroslav Backonja
RBRalf Baron
Ralf Baron
MBMichael Bennett
Michael Bennett
RTRolf-Detlef Treede
Rolf-Detlef Treede
This is a revision of guidelines, originally published in 2004, for the assessment of patients with neuropathic pain. Neuropathic pain is defined as pain arising as a direct consequence of a lesion or disease affecting the somatosensory system either at peripheral or central level. Screening questionnaires are suitable for identifying potential patients with neuropathic pain, but further validation of them is needed for epidemiological purposes. Clinical examination, including accurate sensory examination, is the basis of neuropathic pain diagnosis. For more accurate sensory profiling, quantitative sensory testing is recommended for selected cases in clinic, including the diagnosis of small fiber neuropathies and for research purposes. Measurement of trigeminal reflexes mediated by A-beta fibers can be used to differentiate symptomatic trigeminal neuralgia from classical trigeminal neuralgia. Measurement of laser-evoked potentials is useful for assessing function of the A-delta fiber pathways in patients with neuropathic pain. Functional brain imaging is not currently useful for individual patients in clinical practice, but is an interesting research tool. Skin biopsy to measure the intraepidermal nerve fiber density should be performed in patients with clinical signs of small fiber dysfunction. The intensity of pain and treatment effect (both in clinic and trials) should be assessed with numerical rating scale or visual analog scale. For future neuropathic pain trials, pain relief scales, patient and clinician global impression of change, the proportion of responders (50% and 30% pain relief), validated neuropathic pain quality measures and assessment of sleep, mood, functional capacity and quality of life are recommended.

1 January 2011 in Progress in Neurobiology
Verified
Journal Article
Closed access
VLValéry Legrain
Valéry Legrain
GIGian Domenico Iannetti
Gian Domenico Iannetti
LPLéon Plaghki
Léon Plaghki
AMAndré Mouraux
André Mouraux

1 November 2005 in NeuroImage
Verified
Journal Article
Closed access
RNR.K. Niazy
R.K. Niazy
CBC.F. Beckmann
C.F. Beckmann
GIG.D. Iannetti
G.D. Iannetti
JBJ.M. Brady
J.M. Brady
SSS.M. Smith
S.M. Smith

1 February 2011 in NeuroImage
Verified
Journal Article
Closed access
AMAndré Mouraux
André Mouraux
ADAna Diukova
Ana Diukova
MLMichael C. Lee
Michael C. Lee
RWRichard G. Wise
Richard G. Wise
GIGian Domenico Iannetti
Gian Domenico Iannetti

6 July 2010 in Experimental Brain Research
Verified
Journal Article
Closed access
PDF file
GIG. D. Iannetti
G. D. Iannetti
AMAndré Mouraux
André Mouraux

1 September 2008 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
AMAndré Mouraux
André Mouraux
GIG.D. Iannetti
G.D. Iannetti